Back to Top
Go Back
Journal Photo for Schizophrenia Bulletin
Peer reviewed only Open Access

Schizophrenia Bulletin (SB)

Publisher : Maryland Psychiatric Research Center and Oxford University Press
Etiology Pathophysiology
e-ISSN 1745-1701
Issue Frequency Quarterly
Impact Factor 6.7
Est. Year 1969
Mobile 4107063100
Country United Kingdom
Language English
APC YES
Impact Factor Assignee Google Scholar
Email StudentResearch@som.umaryland.edu

Journal Descriptions

Schizophrenia Bulletin seeks to publish recent developments and empirically based hypotheses regarding the etiology, pathophysiology and treatment of schizophrenia and related disorders. We view the field as broad and deep and will publish new knowledge ranging from molecular to social and cultural factors. We will give new emphasis to translational reports which simultaneously highlight basic neurobiological mechanisms and clinical manifestations. Some of the Bulletin content is invited as special features or manuscripts organized as a theme by special guest editors. Most pages of the Bulletin are devoted to unsolicited manuscripts of high quality that report original data or where we can provide a special venue for a major study or workshop report. Supplement issues are sometimes arranged for reports from a recent conference or proposed to highlight a specific area. The editorial policy of the Schizophrenia Bulletin generally follows the Uniform Requirements guidelines articulated by the International Committee of Medical Journal Editors. The journal publishes six issue a year and has an international readership. The Bulletin is an ideal venue for special reports such as treatment guidelines or changes in nosology. The Bulletin will publish At Issue articles expressing opposing views on controversial scientific issues, succinct discourses on clinical and basic neuroscience concepts, and brief essays on the role of specific environmental and genetic factors in schizophrenia. Schizophrenia Bulletin will continue the tradition of the front cover display of art from artists with mental illness and first person accounts informing on the lived experience of psychosis.

Schizophrenia Bulletin (SB) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Etiology, Pathophysiology , Online , Quarterly Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1745-1701, Established: 1969, Impact Factor: 6.7
  • Does Not Provide Crossref DOI
  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of SB

Peter B Jones January, 2021
Minor neurological signs are subtle deficits in sensory integration, motor coordination, and sequencing of complex motor acts present in excess in the early stages of psychosis. Still, it re...
Peter B Jones May, 2020
Background Insulin Resistance (IR) predisposes to cardiometabolic disorders, which are common in schizophrenia and are associated with excess morbidity and mortality. The mechanisms of asso...
Peter B Jones April, 2020
Background A number of psychological symptoms have been found to predict psychosis. Many studies have found no specificity to separate symptoms predicting non-psychotic psychiatric disorder...
Peter B Jones April, 2020
Background Cardiometabolic risk prediction algorithms are used in clinical practice. Young people with psychosis are a high-risk group for developing cardiometabolic disorders, but it is un...
Peter B Jones May, 2020
Psychotic patients with a lifetime history of cannabis use generally show better cognitive functioning than other psychotic patients. Some authors suggest that cannabis-using patients may ha...
Peter B Jones April, 2020
Background Increasing evidence supports the benefits of regular aerobic exercise for cognition and functioning in schizophrenia. The extent to which these gains are dependent on the amount ...
Graham Murray July, 2019
Development of schizophrenia relates to both genetic and environmental factors. Functional deficits in many cognitive domains, including the ability to communicate in social interactions and...
Peter B Jones April, 2019
Background Schizophrenia affects over 20 million people worldwide through a wide range of symptoms. As an incurable disorder, the disease management is normally based in antipsychotics, whi...
Peter B Jones April, 2019
Background Importance: Associations between childhood infection, IQ and adult non-affective psychosis (NAP) are well established. However, examination of sensitive periods for exposure, eff...
Peter B Jones April, 2019
Background Subclinical metabolic dysfunction and inflammation have been associated with early psychosis and depression, suggesting the possibility of an intrinsic association. This may be d...